SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001171843-22-007790
Filing Date
2022-12-02
Accepted
2022-12-02 16:00:50
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 cmpx20221201_s3.htm S-3 304853
2 EXHIBIT 5.1 ex_452587.htm EX-5.1 7049
3 EXHIBIT 23.1 ex_452512.htm EX-23.1 2667
4 EXHIBIT FILING FEES ex_452194.htm EX-FILING FEES 35411
5 cmpx20221201_s3img001.jpg GRAPHIC 3784
6 cmpx20221201_s3img002.jpg GRAPHIC 5688
7 goodwin.jpg GRAPHIC 31626
  Complete submission text file 0001171843-22-007790.txt   407834
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268652 | Film No.: 221441867
SIC: 2836 Biological Products, (No Diagnostic Substances)